Related Experiment Video
Updated: Jun 24, 2026
11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Broad-spectrum drugs against viral agents
Mary E Christopher1, Jonathan P Wong1
1Defence Research & Development Canada - Suffield, Box 4000, Station Main, Medicine Hat, AB, Canada.
International Journal of Molecular Sciences
|March 28, 2009
Summary
Broad-spectrum antivirals like double-stranded RNAs (dsRNAs) and CpG oligonucleotides (ODNs) boost innate immunity. These immune stimulants offer protection against diverse pathogens, overcoming limitations of specific antiviral treatments.
Area of Science:
- Immunology
- Virology
- Drug Discovery
Background:
- Current antiviral development prioritizes vaccines and specific viral agents.
- These targeted approaches face limitations with unknown pathogens or rapidly mutating viruses.
- Augmenting the innate immune response presents a promising alternative for disease management.
Purpose of the Study:
- To explore the potential of non-specific, broad-spectrum immune response inducers as an alternative antiviral strategy.
- To evaluate the efficacy of double-stranded RNAs (dsRNAs) and CpG oligonucleotides (ODNs) in augmenting innate immunity.
Main Methods:
- Induction of non-specific, broad-spectrum immune responses using double-stranded RNAs (dsRNAs) such as poly (ICLC).
- Utilizing oligonucleotides (ODNs) containing unmethylated deoxynucleotide sequences (CpG motifs) to stimulate immune pathways.
Main Results:
- Demonstrated that dsRNAs and CpG ODNs can effectively induce broad-spectrum immune responses.
- These immune stimulants show potential for protection against a wide range of bacterial and viral pathogens.
Conclusions:
- Nonspecific immune augmentation via dsRNAs and CpG ODNs offers a versatile approach to disease amelioration.
- This strategy provides protection irrespective of pathogen genetic makeup, origin, or drug resistance, addressing limitations of conventional antivirals.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...